Simon Michel
Investment Committee
Simon is CEO of Ypsomed, the leader in self-injection systems for treatment of chronic disease, chair of our key partner the DCB, a global center for diabetes technology innovation dedicated to transforming diagnosis & treatment & improving quality of life for people with diabetes, & has held various other board, trustee & advisory roles including at Unitectra, sitem-insel, Forster Rohner, LEM Surgical & Swiss Medtech.